EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leptin Drives Breast Cancer Aggressiveness Acting Through the Activation of the NCOA1/STAT3 Pathway

Khouloud Ayed iD, Amal Gorrab, Hichem Bouguerra, Rym Akrout iD, Sami Zekri iD, Wassim Y Almawi, Rahma Boughriba, Khalil Choukri iD, Dhouha Bacha iD, Alessandra Pagano, Jean-François Louet iD, Hervé Kovacic iD und 2 weitere

Medical Sciences · 2026

DOI: 10.3390/medsci14010032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Khouloud Ayed und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092…. Hauptthemen laut MEDLINE: Leptin, STAT3 Transcription Factor, Breast Neoplasms, Nuclear Receptor Coactivator 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Tunisian Ministry of Higher Education and Scientific Research, PHC-Utique, INSERM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obesity-associated hyperleptinemia has been linked to breast cancer (BC) progression via mechanisms that remain incompletely understood. This study explores the role of leptin and its receptor (LEPR) in facilitating BC cell proliferation, migration, epithelial–mesenchymal transition (EMT), and STAT3 signaling pathway activation.

Methods

We analyzed gene expression and survival data from TCGA BRCA dataset. MCF-7 and MDA-MB-231 BC cells were exposed to leptin at 10 ng/mL (lean-associated levels) and 100 ng/mL (elevated levels linked to obesity). MTT assays, colony formation tests, wound-healing and tumor spheroid dissemination experiments evaluated cell proliferation and migration. Immunofluorescence and Western blot analysis assessed changes in EMT markers and cytoskeletal alterations, while Western blotting and qPCR assessed STAT3 and NCOA1 expression and activation levels.

Results

Elevated LEPR expression was linked with unfavorable prognosis in BC patients. Higher doses of leptin (100 ng/mL) significantly enhanced cellular proliferation rates and migratory capabilities, in both cell lines, and promoted EMT characteristics marked by downregulated E-cadherin and cytoskeleton structural changes. Whereas heightened JAK2/STAT3 signaling correlated with elevated leptin dosages, STAT3 inhibition using AG490 reversed leptin-induced migration while reinstating E-cadherin levels to baseline. Furthermore, leptin upregulated NCOA1, an essential STAT3 coactivator, facilitating increased expression of Cyclin D1 and VEGF target genes. Clinical positive relationships were seen between LEP/LEPR expressions and NCOA1 levels and between NCOA1 and various gene signatures related to STAT3/P-STAT3 within BC specimens.

Conclusions

Obesity-associated hyperleptinemia enhances aggressiveness in BC through a mechanism involving LEPR-mediated activation pathways encompassing NCOA1/STAT3, which drive proliferation, migration, and EMT. This assigns a potential therapeutic utility for obesity-related advancements found within BC pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptinSTAT3 Transcription FactorBreast NeoplasmsNuclear Receptor Coactivator 1HumansFemaleSignal TransductionCell MovementCell ProliferationEpithelial-Mesenchymal TransitionMDA-MB-231 CellsReceptors, LeptinMCF-7 CellsGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

breast cancerepithelial–mesenchymal transitionleptinobesitytumor migration

Substanzen

LeptinSTAT3 Transcription FactorSTAT3 protein, humanReceptors, LeptinNuclear Receptor Coactivator 1NCOA1 protein, humanLEPR protein, human

Autor:innen und Institutionen

  • Laboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
  • Confocal Microscopy Unit, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis 1007, Tunisia.
  • Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
  • Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia.
  • Service d'Anatomie Pathologique, Hôpital Mongi Slim, La Marsa 2046, Tunisia.
  • Equipe 9 Cytosquelette et Neurophysiopathologie, Faculté Pharmacie site Timone, UMR7051 Institut de Neuro Physiopathologie (INP), 27 Bd Jean-Moulin, 13005 Marseille, France.

ORCID-Profile: Khouloud Ayed, Rym Akrout, Sami Zekri, Khalil Choukri, Dhouha Bacha, Jean-François Louet, Hervé Kovacic, Mounia Tannour-Louet, Asma Gati

Förderung

  • The Tunisian Ministry of Higher Education and Scientific Research
  • PHC-Utique
  • INSERM
  • The Institut National Du Cancer
  • Tunisian Ministry of Higher Education and Scientific Research
  • Institut National du Cancer
  • Association de Recherche contre le Cancer

Zitieren

APA

Ayed, K., Gorrab, A., Bouguerra, H., Akrout, R., Zekri, S., Almawi, W. Y., Boughriba, R., Choukri, K., Bacha, D., Pagano, A., Louet, J. F., Kovacic, H., Tannour-Louet, M., & Gati, A. (2026). Leptin Drives Breast Cancer Aggressiveness Acting Through the Activation of the NCOA1/STAT3 Pathway. Medical Sciences. https://doi.org/10.3390/medsci14010032

Vancouver

Ayed K, Gorrab A, Bouguerra H, Akrout R, Zekri S, Almawi WY, et al. Leptin Drives Breast Cancer Aggressiveness Acting Through the Activation of the NCOA1/STAT3 Pathway. Medical Sciences. 2026. doi:10.3390/medsci14010032

BibTeX
@article{Ayed2026,
  author = {Ayed, Khouloud and Gorrab, Amal and Bouguerra, Hichem and Akrout, Rym and Zekri, Sami and Almawi, Wassim Y and Boughriba, Rahma and Choukri, Khalil and Bacha, Dhouha and Pagano, Alessandra and Louet, Jean-François and Kovacic, Hervé and Tannour-Louet, Mounia and Gati, Asma},
  title = {Leptin Drives Breast Cancer Aggressiveness Acting Through the Activation of the NCOA1/STAT3 Pathway},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14010032}
}
Kostenlos starten →